Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1714076

registered interest
date	26/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Trastuzumab Deruxtecan
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what representations she has made to NICE on the availability of Enhertu.
tabling member constituency	Brentford and Isleworth
tabling member printed	Ruth Cadbury
uin	23881
answer	answer is ministerial correction date of answer 02/05/2024 answer text <p>The Department meets regularly with the National Institute for Health and Care Excellence (NICE) to discuss a range of issues, including access to medicines. The NICE has recommended Enhertu, also known as trastuzumab deruxtecan and made by Daiichi Sankyo, for use through the Cancer Drugs Fund, for the treatment of HER2-positive metastatic or unresectable breast cancer. It is available to eligible National Health Service patients in England, in line with the NICE’s recommendations.</p><p>The NICE is currently evaluating Enhertu for the treatment of HER2-low metastatic or unresectable breast cancer. Following negotiations between NHS England and the company, which concluded without a commercial agreement to make it available at a cost-effective price for the NHS, the NICE published final draft guidance on 5 March 2024, that does not recommend it as an option for this indication. The NICE remains open to further discussions with NHS England and the company, and currently expects to publish final guidance on 15 May 2024.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 02/05/2024 11:47:11 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4389 label Biography information for Ruth Cadbury

1714079

registered interest
date	26/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Gabapentin
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she has had recent discussions with the Medicines and Healthcare products Regulatory Agency on (a) its advice on prescribing and (b) the side effects of gabapentin.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	23890
answer	answer is ministerial correction date of answer 01/05/2024 answer text <p>Gabapentin is authorised for the treatment of some forms of epilepsy, as well as peripheral neuropathic pain. The product information for gabapentin, approved by the Medicines and Healthcare products Regulatory Agency (MHRA), provides information to support the prescribing of the medication including recommendations for dose, duration of use, as well as gradual reduction when stopping. The product information includes warnings about possible side effects.</p><p>The MHRA continuously monitors the safety of gabapentin and ensures the product information reflects what is known about the medicine and its side effects.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 01/05/2024 09:02:05 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4471 label Biography information for Rachael Maskell

1714080

registered interest
date	26/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Gabapentin
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will take steps to ensure that people experiencing acute or chronic side effects from taking gabapentin do not have to wait for a (a) referral and (b) assessment by mental health services.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	23891
answer	answer is ministerial correction date of answer 01/05/2024 answer text <p>While we have no specific plans to do so, we are committed to expanding and transforming mental health services in England through the NHS Long Term Plan, so that more people, including those experiencing side effects from taking gabapentin, can get the mental health help and support that they need.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 01/05/2024 15:56:56 answering member 4492 label Biography information for Maria Caulfield
tabling member	4471 label Biography information for Rachael Maskell

1714081

registered interest
date	26/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Alcoholic Drinks: Children and Young Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps she is taking with Cabinet colleagues to help tackle under-age alcohol use.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	23892
answer	answer is ministerial correction date of answer 01/05/2024 answer text <p>Guidance from England’s Chief Medical Officer for healthcare professionals is clear, an alcohol-free childhood is the healthiest and best option. The Department promotes this through online platforms such as the NHS.UK website, and the Talk to FRANK online resource. Local authorities promote these guidelines as part of their public health duties.</p><p>The Department for Education’s statutory guidance, Relationships education, relationships and sex education and health education, became mandatory in September 2020. Through this, education on drugs, alcohol, and tobacco became compulsory at state-funded primary and secondary schools, teaching children and young people how to manage influences and pressures, and keep themselves healthy and safe.</p><p>To deter individuals selling alcohol to a person aged under 18 years old, the maximum fine for the offence of persistently selling alcohol to children was increased from £10,000 to £20,000, under s 147A(8) of the 2003 Licensing Act.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 01/05/2024 12:20:25 answering member 4117 label Biography information for Andrea Leadsom
tabling member	4471 label Biography information for Rachael Maskell

1714082

registered interest
date	26/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Alcoholic Drinks: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment has she made of the potential implications for her policies of public health approaches to alcohol from other countries; and whether she has made an assessment of which country provides the best practice model.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	23893
answer	answer is ministerial correction date of answer 07/05/2024 answer text <p>The Department maintains an interest in the effectiveness of policies implemented by other countries, to reduce alcohol harms. The 2016 Public Health England publication, The public health burden of alcohol: evidence review, reviewed effective policies for reducing alcohol harms in countries who are members of the Organisation for Economic Co-operation and Development. Officials in the Department frequently engage with international colleagues, and those in the devolved administrations, to exchange ideas, experience, and evidence when developing new policies.</p><p>The Government was involved in the work by the World Health Organization (WHO) to develop an action plan to strengthen the implementation of the Global Strategy to Reduce the Harmful Use of Alcohol. We were pleased that the action plan was adopted at the 75th World Health Assembly in May 2022. The United Kingdom will continue to work with the WHO and member states on alcohol harm reduction.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 07/05/2024 13:15:57 answering member 4117 label Biography information for Andrea Leadsom
tabling member	4471 label Biography information for Rachael Maskell

1714083

registered interest
date	26/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Alcoholic Drinks: Children and Young Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to help educate children on alcohol harm.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	23894
answer	answer is ministerial correction date of answer 07/05/2024 answer text <p>The Department for Education’s statutory guidance, Relationships education, relationships and sex education and health education, became mandatory in September 2020. Through this, education on drugs, alcohol, and tobacco became compulsory at state-funded primary and secondary schools, teaching children and young people how to manage influences and pressure, and keep themselves healthy and safe.</p><p>The Government also has an information and advice service called Talk to FRANK, which aims to reduce the use of substances and their harms, by providing awareness to young people, parents, and concerned others. Further information is available at the following link:</p><p><a href="https://www.talktofrank.com" target="_blank">https://www.talktofrank.com</a></p><p>Guidance from England’s Chief Medical Officer for healthcare professionals is clear, that an alcohol-free childhood is the healthiest and best option. The Department promotes these through online platforms such as NHS.UK website, the Talk to FRANK online resource, and the GOV.UK website. Local authorities promote these guidelines as part of their public health duties.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 07/05/2024 13:19:46 answering member 4117 label Biography information for Andrea Leadsom
tabling member	4471 label Biography information for Rachael Maskell

1714084

registered interest
date	26/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Alcoholic Drinks: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what criteria she uses to assess the success of Government policy on (a) alcohol use and (b) alcohol harm.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	23895
answer	answer is ministerial correction date of answer 07/05/2024 answer text <p>We have a range of metrics which we monitor to assess the success of our work to reduce alcohol harm, including the Health Survey for England. The Government takes a wide-ranging approach to addressing alcohol-related harms, including promoting the United Kingdom’s Chief Medical Officer’s low risk drinking guidance. Approximately 80% of adults drink within the guidelines of 14 units of alcohol a week.</p><p>Population level alcohol consumption has remained stable over recent years. Among children aged 11 to 15 years old, alcohol consumption has decreased significantly in the last 20 years. However, while we are seeing an increasing number of people drinking at lower levels or abstaining, we have also seen more people drinking at higher-risk levels. As a result, some indicators of harm have increased, and we are committed to addressing these, including through the establishment of alcohol care teams in the 25% acute hospitals in England with the greatest need, through the NHS Long Term Plan.</p><p>Community treatment for alcohol dependence is highly effective. In 2020/21, 62% of people in alcohol-only treatment completed treatment free of dependence, the highest completion rate for any substance misuse group. We have committed to making further improvements to the alcohol and drug treatment system through the 10-year Drug Strategy.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 07/05/2024 13:12:58 answering member 4117 label Biography information for Andrea Leadsom
tabling member	4471 label Biography information for Rachael Maskell

1714085

registered interest
date	26/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Alcoholic Drinks: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if she will undertake a review of her strategy on alcohol use through a harm reduction approach.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	23896
answer	answer is ministerial correction date of answer 15/05/2024 answer text <p>The Government takes a wide-ranging approach to reducing alcohol related harms. Several aspects of the Department's work to address alcohol related harms already follows a harm reduction approach. These include the UK Chief Medical Officers’ low-risk drinking guidelines, which recommend that people moderate their drinking to 14 units a week, and guidance from England’s Chief Medical Officer for healthcare professionals, on the consumption of alcohol by young people. The National Health Service’s Better Heath campaign aims to motivate people to take steps to improve their health, including in relation to alcohol use, and the NHS Health Check provides an opportunity for general practitioners to offer advice to reduce alcohol use, if appropriate.</p><p>In relation to treatment, the Department is committed to promoting access to alcohol services through our drug strategy. The upcoming UK clinical guidelines for alcohol treatment will include a chapter on taking a harm reduction approach within alcohol treatment, which outlines a flexible service approach. The Department, in partnership with the devolved administrations, will publish these guidelines later this year.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 15/05/2024 13:51:51 answering member 4117 label Biography information for Andrea Leadsom
tabling member	4471 label Biography information for Rachael Maskell

1714094

registered interest
date	26/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Heart Diseases: Surgery
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to help increase the availability of heart valve surgery for (a) women and (b) ethnic minorities.
tabling member constituency	Sheffield, Brightside and Hillsborough
tabling member printed	Gill Furniss
uin	23907
answer	answer is ministerial correction date of answer 01/05/2024 answer text <p>NHS England continues to work with its partners in raising awareness of aortic stenosis, with a particular focus on women. NHS England is also working to increase access to cardiac surgery. The breathlessness pathway, launched in April 2023, encourages general practitioners to examine all patients for the signs of valvular heart disease. Heart valve disease is a focus for cardiac networks, with pathways in in place to improve early detection of valve disease in the community.</p><p>In November 2023, a dedicated Heart Valve Disease (HVD) Expert Advisory Group was convened to provide NHS England’s Cardiac Transformation Programme with leadership, advice, quality assurance, expert review, and endorsement of the projects and deliverables that comprise the HVD workstream, with a focus on improving the speed and equity of access to high quality treatment for heart valve patients.</p><p>To improve the early detection and diagnosis of heart valve disease across England, including aortic stenosis, £2.3 billion has been committed to open 160 community diagnostic centres by March 2025. This will increase the volume of diagnostic activity and further reduce patient waiting times. The centres have delivered over 5 million additional tests since July 2021, including those that detect cardiovascular disease.</p><p>In addition, the National Health Service is investing in cardiac networks to support whole pathway improvements. These networks have been developed to take an evidenced based, clinically led, whole pathway approach to improvement, from prevention, diagnosis, treatment, and through to end-of-life care.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 23908 question first answered 01/05/2024 08:52:14 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4571 label Biography information for Gill Furniss

1714095

registered interest
date	26/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Heart Diseases: Women
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to help increase awareness of the symptoms of heart valve disease in women.
tabling member constituency	Sheffield, Brightside and Hillsborough
tabling member printed	Gill Furniss
uin	23908
answer	answer is ministerial correction date of answer 01/05/2024 answer text <p>NHS England continues to work with its partners in raising awareness of aortic stenosis, with a particular focus on women. NHS England is also working to increase access to cardiac surgery. The breathlessness pathway, launched in April 2023, encourages general practitioners to examine all patients for the signs of valvular heart disease. Heart valve disease is a focus for cardiac networks, with pathways in in place to improve early detection of valve disease in the community.</p><p>In November 2023, a dedicated Heart Valve Disease (HVD) Expert Advisory Group was convened to provide NHS England’s Cardiac Transformation Programme with leadership, advice, quality assurance, expert review, and endorsement of the projects and deliverables that comprise the HVD workstream, with a focus on improving the speed and equity of access to high quality treatment for heart valve patients.</p><p>To improve the early detection and diagnosis of heart valve disease across England, including aortic stenosis, £2.3 billion has been committed to open 160 community diagnostic centres by March 2025. This will increase the volume of diagnostic activity and further reduce patient waiting times. The centres have delivered over 5 million additional tests since July 2021, including those that detect cardiovascular disease.</p><p>In addition, the National Health Service is investing in cardiac networks to support whole pathway improvements. These networks have been developed to take an evidenced based, clinically led, whole pathway approach to improvement, from prevention, diagnosis, treatment, and through to end-of-life care.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 23907 question first answered 01/05/2024 08:52:14 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4571 label Biography information for Gill Furniss